Gilles Huberfeld

Title: Gilles Huberfeld: Innovator in Neurological Treatments

Introduction

Gilles Huberfeld is a notable inventor based in Garches, France. He has made significant contributions to the field of neurology, particularly in the treatment of epileptic diseases. His innovative approach has led to the development of a unique pharmaceutical application that addresses critical health issues.

Latest Patents

Gilles Huberfeld holds a patent for the use of Probenecid in treating epileptic diseases, disorders, or conditions. The patent describes Probenecid or a pharmaceutical acceptable salt thereof for use in the treatment of a neurological disorder in a subject in need thereof. The administration of Probenecid effectively controls clinical or electrographic seizures in the subject. This treatment specifically targets neurological disorders, with a focus on epileptic diseases, disorders, or conditions. He has 1 patent to his name.

Career Highlights

Throughout his career, Gilles Huberfeld has worked with prestigious institutions such as Paris Sciences et Lettres and the Centre National de la Recherche Scientifique. His work in these organizations has allowed him to advance his research and contribute to significant developments in the field of neurology.

Collaborations

Gilles has collaborated with notable colleagues, including Nathalie Rouach and Eléna Dossi. Their combined expertise has fostered an environment of innovation and research excellence.

Conclusion

Gilles Huberfeld's contributions to the treatment of neurological disorders, particularly epilepsy, highlight his role as a key innovator in the field. His patent for Probenecid showcases his commitment to improving patient outcomes through scientific advancements.